AstraZeneca (AZN)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

2,634.50p
   
  • Change Today:
    -17.00p
  • 52 Week High: 3,194.00
  • 52 Week Low: 2,543.50
  • Currency: UK Pounds
  • Shares Issued: 1,266.58m
  • Volume: 2,032,315
  • Market Cap: £33,368m
  • RiskGrade: 102
  • Beta: 0.76

Latest ShareCast News

Wednesday newspaper round-up: Greece, RBS, AstraZeneca

Date: Wednesday 16 May 2012

As leaders in Athens accepted the need for a new general election to end a national stalemate, the International Monetary Fund said Europe’s leaders should prepare for the possibility of a Greek departure from the single currency. Christine Lagarde, head of the IMF, warned she was “technically prepared for anything” and said the utmost effort must be made to ensure any Greek exit was orderly. The effect was likely to be “quite messy” with risks to growth, trade and financial markets. “It is something that would be extremely expensive and would pose great risks but it is part of options that we must technically consider,” she said. Raising tensions still further, Germany warned Greek voters that the wrong result in next month’s election will force their country out of the single currency, according to The Telegraph.

AstraZeneca ShareCast News

Broker snap: With new leader, it's Astra's 'time... 04-May-2012 ShareCast
FTSE 100 movers: RBS flying high on results update 04-May-2012 ShareCast
London midday: Stocks lower before US non-farm p... 04-May-2012 ShareCast
Friday broker round-up 04-May-2012 ShareCast
London midday: Footsie down as Man Group provide... 30-Apr-2012 ShareCast

AstraZeneca Regulatory News

Transaction in Own Shares 16-May-2012 07:00 RNS
Transaction in Own Shares 15-May-2012 07:00 RNS
Transaction in Own Shares 14-May-2012 07:00 RNS
Transaction in Own Shares 11-May-2012 07:00 RNS
Transaction in Own Shares 10-May-2012 07:00 RNS

AstraZeneca Newspaper Links

AstraZeneca staff find new jobs ahead of plant c... 30-Dec-2011 Telegraph
AstraZeneca back on top with new drug deals 22-Dec-2011 Daily Mail
ASTRAZENECA TURNS TO ASIA 22-Dec-2011 Express & Star
Chi-Med in £89m deal with Astra 22-Dec-2011 The Scotsman
Astra snaps up generic drug firm in China 09-Dec-2011 The Independent

AstraZeneca Tips & Analysis

Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent
FTSE live: Banks lead gains, AZ relief 28-Mar-2011 Daily Mail
Patent Woes Threaten Drug Firms 07-Mar-2011 New York Times

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Other AstraZeneca News

FTSE close: Next up; Barclays & UU down 22-Jun-2011 This Is Money
Midas: At last, Dogs are setting the pace 14-May-2011 This Is Money
How to enjoy the dividend revival 14-May-2011 This Is Money
FTSE in-depth: Greene King the toast of analysts 13-May-2011 This Is Money
FTSE preview: Rebound led by defensive stocks 13-May-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 2,634.50p
Change Today -17.00p
% Change -0.64 %
52 Week High 3,194.00
52 Week Low 2,543.50
Volume 2,032,315
Shares Issued 1,266.58m
Market Cap £33,368m
Beta 0.76
RiskGrade 102

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.05% above the market average76.05% above the market average76.05% above the market average76.05% above the market average76.05% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Price Trend
36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average
21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average
Income
97.48% above the market average97.48% above the market average97.48% above the market average97.48% above the market average97.48% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
24.65% below the market average24.65% below the market average24.65% below the market average24.65% below the market average24.65% below the market average
91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average

What The Brokers Say

Strong Buy 7
Buy 3
Neutral 19
Sell 7
Strong Sell 6
Total 42
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 15-Feb-12 03-Aug-11
Paid 19-Mar-12 12-Sep-11
Amount 195.00¢ 85.00¢

Trades for 16-May-2012

Time Volume / Share Price
16:51 700 @ 2,633.84p
16:46 63 @ 2,640.00p
16:46 6,913 @ 2,630.57p
16:44 300 @ 2,643.17p
16:44 2,205 @ 2,625.50p

Top of Page